Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples